LONGEVITY 1

Clinical trials for LONGEVITY 1 explained in plain language.

Never miss a new study

Get alerted when new LONGEVITY 1 trials appear

Sign up with your email to follow new studies for LONGEVITY 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Aging clock test: tirzepatide trial targets biological age

Disease control Recruiting now

This pilot study tests whether tirzepatide (Zepbound), a drug already used for weight loss, can slow biological aging in adults aged 55 to 70. Ninety participants with a BMI of 27 or higher will be randomly assigned to receive the drug weekly for 24 weeks or no drug, followed by …

Matched conditions: LONGEVITY 1

Phase: PHASE2 • Sponsor: The University of Texas Medical Branch, Galveston • Aim: Disease control

Last updated Jun 27, 2026 12:00 UTC

LONGEVITY 1

Get alerted when new LONGEVITY 1 trials appear

Aging clock test: tirzepatide trial targets biological age